Compound search：Set keywords and then click SEARCH.
Please contact us by using the Inquiry Form
. We will ask for more details by e-mail, so just a brief description is sufficient. You can also contact us from the page that appears by clicking on the structural formula.
| SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
|---|---|---|---|---|---|
| 05950 |  | Sulforhodamine bis(CO-PEG14-COOH) | 64,600/0.1mg | >95% | 1.6 |
| 06798 |  | Cy5(1-PEG3-OMe 5-SO3H 8,8-diMe 1'-PEG13-COOH 8',8'-diMe) | 119,600/0.1mg | >95% | 0.1 |
| 06461 |  | Cy5(PEG3-OMe)(PEG13-COOtBu) | 119,600/0.1mg | >95% | 0 |
| 06410 |  | Cy7(1-PEG13-COOH 5-SO3H 8,8-diMe 1'-PEG3-OMe 5'-SO3H 8',8'-diMe) | 119,600/0.1mg | >95% | 0.4 |
| 06401 |  | TMSI-PEG13-OTrt | 64,600/0.1mg | >95% | 0 |
| 06396 |  | AADIS7-PEG13-COOH | 119,600/0.1mg | >95% | 0.3 |
| 06390 |  | AADIS7-PEG13-COOtBu | 96,000/0.1mg | >95% | 0.9 |
| 06311 |  | TMSI-PEG13-COOH | 64,600/0.1mg | >95% | 11.1 |
| 06064 |  | Cy7(1-HexCONH-PEG13-COOtBu 5-SO3H 8,8-diMe 1'-Et-SO3H 8',8'-diMe) | 96,000/0.1mg | >95% | 0 |
| 05373 |  | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-CONH-PEG2-Hex-Cl 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 119,600/0.1mg | >90% | 0.1 |
| 05078 |  | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-COOtBu 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 96,000/0.1mg | >90% | 0 |
| 04746 |  | CF660R-PEG13-PEG2-O-HexCl | 119,600/0.1mg | >95% | 0.1 |
| 04731 |  | DY-547-CONH-PEG13-COOH | 69100/<0.1mg | >95% | 0.1 |
| 04730 |  | Texas-Red-X-CONH-PEG13-COOH mixed isomers | 69100/<0.1mg | >95% | 0.1 |
| 06479 |  | Cy5(1-PEG12-OMe 5-SO3H 8,8-diMe 1'-AcOtBu-8',8'-diMe | 64,600/0.1mg | >90% | 0.4 |
| 06456 |  | TMSI-PEG12-OMe | 64,600/0.1mg | >80% | 9.0 |
| 06394 |  | TMSI-PEG12-OH | 119,600/0.1mg | >95% | 6.1 |
| 06518 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Et 5'-SO3H 8'-Me 8'-PEG11-OMe | 64,600/0.1mg | >90% | 0 |
| 06402 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG10-OAc 5'-SO3H 8',8'-diMe) | 64,600/0.1mg | >95% | 0 |
| 06069 |  | TMSI-PEG10-OH | 64,600/0.1mg | >95% | 0.1 |
| 06068 |  | TMSI-PEG10-OTrt | 64,600/0.3mg | >95% | 9.0 |
| 02749 |  | OH-PEG9-SO3H | 63,300/0.9mg | >95% | 16.2 |
| 06295 |  | TMSI-PEG8-OH | 63,300/0.9mg | >95% | 12.8 |
| 06398 |  | TMSI-PEG7-OH | 63,300/0.9mg | >95% | 1.3 |
| 06516 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >90% | 0 |
| 06432 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 |
| 06417 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 |
| 06397 |  | TMSI-PEG6-OH | 63,300/0.9mg | >95% | 1.2 |
| 06796 |  | AADIS5-PEG5-COOH | 63,300/0.9mg | >95% | 0 |
| 06426 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 |
| 06419 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >90% | 0 |
| 06294 |  | TMSI-PEG5-NHTrt | 64,600/0.1mg | >95% | 2.6 |
| 04857 |  | Sulforhodamine bis(piperazine-PEG5-COOH) | 64,600/0.5mg | >95% | 7.0 |
| 06511 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 64,600/0.1mg | >90% | 0 |
| 06509 |  | 1-(5-carboxypentyl)-2-[(E,3Z)-3-[1-ethyl-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 |
| 06473 |  | DMSI(3-PEG4-COOH) | 63,300/0.9mg | >95% | 4.1 |
| 06434 |  | 2-[(E,3Z)-3-[1,3-bis[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-1-[2-[2-(2-carboxyethoxy)ethoxy]ethyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 |
| 06433 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG3-OMe) | 64,600/0.1mg | >90% | 0 |
| 06422 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >90% | 0 |
| 06409 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-N3 8',8'-diMe) | 119,600/0.1mg | >95% | 0 |
| 06405 |  | AADIS7-PEG4-N3 | 64,600/0.1mg | >95% | 2.5 |
| 06293 |  | TMSI-PEG4-Pr-COOH | 63,300/0.9mg | >95% | 0 |
| 06062 |  | Cy7(1-PEG4-COOH 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 96,000/0.1mg | >95% | 0.1 |
| 06059 |  | AADIS7-PEG4-COOMe | 119,600/0.1mg | >95% | 3.9 |
| 06009 |  | Cy7(1-PEG4-COOMe 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 96,000/0.1mg | >95% | 0 |
| 05970 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-OH 8',8'-diMe) | 64,600/0.1mg | >95% | 0 |
| 05948 |  | TMSI-PEG4-OH | 64,600/0.2mg | >95% | 15.7 |
| 05075 |  | AADIS7-PEG3-OAc | 64,600/0.5mg | >95% | 3.0 |
| 03545 |  | TMSI-PEG4-COOMe | 64,600/0.1mg | >95% | 1.6 |
| 06512 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 64,600/0.1mg | >90% | 0 |
| 06431 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 |
| 06430 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >90% | 0 |
| 06425 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 |
| 06423 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 |
| 06421 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 |
| 06420 |  | (3R)-1-(5-carboxypentyl)-2-[(E,3E)-3-[(3S)-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 |
| 06393 |  | TMSI-PEG3-OMe | 63,300/0.9mg | >95% | 11.2 |
| 06061 |  | Cy7(1-Hex-COOH 5-SO3H 8,8-diMe 1'-PEG3-OAc 5'-SO3H 8',8'-diMe) | 96,000/0.1mg | >95% | 0.1 |
| 05146 |  | TMSI-PEG3-OH | 64,600/0.1mg | >95% | 89.4 |
| 02597 |  | Trt-PEG3-PPG1-SO3H | 64,600/10mg | >95% | 186.0 |
| 02065 |  | Trt-PEG3-SSO3H | 63,100/0.6mg | >95% | 26.8 |
| 01636 |  | SO3H-PEG3-OH | 65,700/0.6mg | <80% | 60.0 |
| 01331 |  | Cy5(1-Hex-CONH-PEG3-NH2 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 63,300/0.9mg | >90% | 0 |
| 06515 |  | 2-[(E,3E)-3-[3,3-dimethyl-5-sulfo-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 |
| 06513 |  | 3-[2-[(1E,3E,5Z)-5-[3,3-dimethyl-5-sulfo-1-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-3-[5-[2-(2-hydroxyethoxy)ethylamino]-5-oxo-pentyl]-3-methyl-5-sulfo-indol-1-ium-1-yl]propane-1-sulfonate | 64,600/0.1mg | >95% | 0 |
| 06510 |  | Cy7(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG2-OMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 64,600/0.1mg | >95% | 0 |
| 06440 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 |
| 06439 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >90% | 0 |
| 06843 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-EtOAc 8',8'-diMe) | 64,600/0.3mg | >95% | 1.9 |
| 06841 |  | AADIS5(6-Br)(8-N-Pr-SO3H) | 63,300/0.9mg | >95% | 9.1 |
| 06840 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-EtOH 8',8'-diMe) | 64,600/0.5mg | >95% | 0.7 |
| 06790 |  | 3-(5-bromo-2,3,3-trimethyl-pyrrolo[2,3-b]pyridin-7-yl)propane-1-sulfonic acid | 63,300/0.9mg | >95% | 156.7 |
| 06607 |  | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | 67,600/7.5mg | >95% | 0.2 |
| 06523 |  | Cy7(1-PEG4-COOH 5-SO3H 8,8-di-Me 1'-PEG4-COOH 5'-SO3H 8',8'-diMe)(4-Et-SO3H) | 64,600/0.1mg | >95% | 0 |
| 06522 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 |
| 06521 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 |
| 06520 |  | Cy5(1-PEG4-Pr-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PE4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 64,600/0.1mg | >90% | 0 |
| 06519 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG4-OMe) | 64,600/0.1mg | >95% | 0 |
| 06517 |  | 1-(4-aminobutyl)-2-[(1E,3E,5E)-5-[1-(5-carboxypentyl)-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 119,600/0.1mg | >95% | 0 |
| 06514 |  | 1-ethyl-2-[(E,3E)-3-[1-[6-(2-hydroxyethoxy)-6-oxo-hexyl]-3,3-dimethyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 |
| 06446 |  | 3-[2-[2-[(2E)-2-[(E)-3-[3,3-dimethyl-1-[2-[2-(3-sulfopropoxy)ethoxy]ethyl]indol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethyl-indolin-1-yl]ethoxy]ethoxy]propane-1-sulfonic acid | 64,600/0.1mg | >95% | 0 |
| 06418 |  | Cy7(1-PEG5-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 64,600/0.1mg | >95% | 0 |
| 06416 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 |
| 06297 |  | AADIS5-Et-OAc | 64,600/0.2mg | >95% | 8.0 |
| 06296 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 96,000/0.1mg | >90% | 0.9 |
| 06114 |  | AADIS7-Et-SO3H | 64,600/0.1mg | >80% | 7.6 |
| 06035 |  | TMSI-Et-SO3H | 64,600/0.5mg | >80% | 20.4 |
| 05969 |  | AADIS5-Hex-COOH | 63,300/0.9mg | >95% | 1.0 |
| 05968 |  | 2-[4-[6'-[4-(carboxymethyl)piperazin-1-yl]-1,1-dioxo-spiro[2,1-ramda-benzoxathiole-3,9'-xanthene]-3'-yl]piperazin-1-yl]acetic acid | 64,600/0.1mg | >95% | 1.0 |
| 05967 |  | 2-[4-(1,1-dioxo-6'-piperazin-1-yl-spiro[2,1-ramda--benzoxathiole-3,9'-xanthene]-3'-yl)piperazin-1-yl]acetic acid | 64,600/0.1mg | >95% | 0 |
| 05959 |  | AADIS5-Me | 64,600/0.2mg | >95% | 9.3 |
| 05955 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-Hex-COOH 5'-SO3H 8',8'-diMe) | 64,600/0.2mg | >90% | 0.1 |
| 05954 |  | AADIS7-Hex-COOH | 64,600/0.1mg | >95% | 0.1 |
| 05945 |  | TMSI-acetoxyacetic acid | 64,600/0.1mg | >95% | 5.3 |
| 05944 |  | TMSI-Me | inquire | >95% | 3.3 |
| 05941 |  | AADIS5-HexCOOH | 63,300/0.9mg | >95% | 31.2 |
| 05940 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Hex-COOH 5'-SO3H 8',8'-diMe) | 63,300/0.9mg | >90% | 0.5 |
| 05393 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-Et-SO3H 8',8'-diMe) | 64,600/0.1mg | >95% | 0.1 |
| 05364 |  | AADIS5-Et-SO3H | 96,000/0.1mg | >95% | 2.4 |
| 05342 |  | Sodium 4-dodecylbenzenesulfonate | inquire | >95% | 30.0 |
| 05314 |  | p-n-Dodecylbenzenesulfonic Acid Sodium Salt 13C6 | inquire | >95% | 5.8 |
| 05148 |  | Sulfo-Cy3 bis(IAA) | 64,600/0.2mg | >95% | 0.1 |
| 05147 |  | Sulfo Cy3-diamine | 64,600/0.2mg | >95% | 5.0 |
| 05143 |  | Sulfo-Cy3 | 64,600/0.5mg | >95% | 2.6 |
| 05142 |  | TMSI-Et-OH | 72,000/5mg | >95% | 325.6 |
| 05141 |  | TMSI-acetic acid | 64,600/0.3mg | >95% | 13.3 |
| 05132 |  | TMSI-Et-NH2 | 64,600/5mg | >95% | 22.7 |
| 05130 |  | Suflo-Cy3 | 63,300/0.9mg | >95% | 4.7 |
| 05094 |  | PFOS | 63,300/0.9mg | >99% | 2.8 |
| 05072 |  | AADIS7-Me | 64,600/0.3mg | >95% | 1.7 |
| 05048 |  | Bentazone-D7 | 88,000/20mg | >95% | 0 |
| 04852 |  | bis-(IAA-piperazinyl) sulforhodamine | 64,600/0.3mg | >95% | 0.9 |
| 04148 |  | 3-[(7-aminophenothiazin-5-ium-3-yl)-(3-sulfopropyl)amino]propane-1-sulfonate(mix isomers) | 64,600/0.1mg | >95% | 3.8 |
| 04136 |  | TMSI-Hex-COOH | inquire | >90% | 740.6 |
| 04084 |  | Ethanesulfonic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]- | 64,600/10mg | >95% | 400.0 |
| 04080 |  | Ethanesulfonic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]- | 65,600/25mg | >95% | 300.0 |
| 03666 |  | 1-amino-4-(dimethylamino)-2-sulfosulfanyl-benzene | 66,400/500mg | >95% | 5,749.6 |
| 03607 |  | TMSI-K salt | inquire | >90% | 6,570.9 |
| 01980 |  | Cy3-halolinker | 64,600/0.3mg | >95% | 0.1 |
| 01516 |  | Arsenosugar monosulfate | 200,000/<0.1mg | >95% | 0.2 |
| 00651 |  | 4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide-d4 | 68,000/10mg | >95% | 817.0 |
| 00583 |  | C10-SPC | 75,000/10mg | >95% | 15.0 |
| 00582 |  | C8-SPC | 96,000/0.1mg | >95% | 105.0 |
| 00413 |  | 1H-Imidazolium, 1,2-dimethyl-3-[(2,2,2-trichloroethoxy)sulfonyl]-, 1,1,1-trifluoromethanesulfonate | 65,600/25mg | >95% | 466.0 |
| 00352 |  | 2,2,2-Trichloroethyl chlorosulfate | inquire | <80% | 2,521.7 |
